HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Women’s Voices Join In Fragrance Disclosure Debate, Citing Allergy Risks

This article was originally published in The Rose Sheet

Executive Summary

NGO Women’s Voices for the Earth says the rising incidence of fragrance allergy worldwide points to a need for fragrance ingredient disclosure. In an online petition, the group is calling on IFRA to establish “an industry-wide policy” of full transparency so consumers can make informed choices about fragranced product use.

You may also be interested in...



Feinstein Bill To Mandate Fragrance Ingredient Contacts, Not Disclosure

Cosmetics legislation poised for introduction in the Senate is likely to uphold the trade-secret status of fragrance compositions, promoting “a direct communication line” between FDA and fragrance houses rather than requiring full disclosure of fragrance ingredients, according to IFRA North America.

IFRA Report To EC Addresses Trade Secrets, Dangers Of Full Disclosure

Safeguarding trade secrets “remains the most practical and efficient means of protecting the intangible assets” produced by innovation in the fragrance industry, IFRA asserts in a recently issued report. Threats to the industry’s intellectual property, including calls for full disclosure of formulas, put the market at risk, the group says.

Phthalates, Lead, Fragrance Materials Among “Unfounded” Scares Of 2012

The American Council on Science and Health again includes media frenzies around ingredients in cosmetic products on its annual list of the Top Ten Unfounded Health Scares.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS018917

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel